» Articles » PMID: 32266655

Matrix Metalloproteinases' Role in Tumor Microenvironment

Overview
Date 2020 Apr 9
PMID 32266655
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer cells evolve in the tumor microenvironment (TME) by the acquisition of characteristics that allow them to initiate their passage through a series of events that constitute the metastatic cascade. For this purpose, tumor cells maintain a crosstalk with TME non-neoplastic cells transforming them into their allies. "Corrupted" cells such as cancer-associated fibroblasts (CAFs), tumor-associated macrophages (TAMs), and tumor-associated neutrophils (TANs) as well as neoplastic cells express and secrete matrix metalloproteinases (MMPs). Moreover, TME metabolic conditions such as hypoxia and acidification induce MMPs' synthesis in both cancer and stromal cells. MMPs' participation in TME consists in promoting events, for example, epithelial-mesenchymal transition (EMT), apoptosis resistance, angiogenesis, and lymphangiogenesis. MMPs also facilitate tumor cell migration through the basement membrane (BM) and extracellular matrix (ECM). The aim of the present chapter is to discuss MMPs' contribution to the evolution of cancer cells, their cellular origin, and their influence in the main processes that take place in the TME.

Citing Articles

The Role of Epithelial-Mesenchymal Transition in Osteosarcoma Progression: From Biology to Therapy.

Patrascu A, Tarca E, Lozneanu L, Ungureanu C, Morosan E, Parteni D Diagnostics (Basel). 2025; 15(5).

PMID: 40075892 PMC: 11898898. DOI: 10.3390/diagnostics15050644.


Cathepsins and their role in gynecological cancers: Evidence from two-sample Mendelian randomization analysis.

Li X, Sun L, Wu X, Qiu M, Ma X Medicine (Baltimore). 2025; 104(10):e41653.

PMID: 40068078 PMC: 11902974. DOI: 10.1097/MD.0000000000041653.


From silent partners to potential therapeutic targets: macrophages in colorectal cancer.

Khizar H, Ali K, Wang J Cancer Immunol Immunother. 2025; 74(4):121.

PMID: 39998578 PMC: 11861851. DOI: 10.1007/s00262-025-03965-w.


DCLK1-mediated regulation of invadopodia dynamics and matrix metalloproteinase trafficking drives invasive progression in head and neck squamous cell carcinoma.

Arnold L, Yap M, Farrokhian N, Jackson L, Barry M, Ly T Mol Cancer. 2025; 24(1):50.

PMID: 39994636 PMC: 11853957. DOI: 10.1186/s12943-025-02264-3.


Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.

Glaviano A, Lau H, Carter L, Lee E, Lam H, Okina E J Hematol Oncol. 2025; 18(1):6.

PMID: 39806516 PMC: 11733683. DOI: 10.1186/s13045-024-01634-6.